Federal Register / Vol. 87, No. 15 / Monday, January 24, 2022 / Notices 3563 

Collection Clearance Officer at: 

Evonne.Bennett@ihs.gov or 301–443– 

4750. 

SUPPLEMENTARY INFORMATION: This 

previously approved information 

collection project was last published in 

the Federal Register on September 25, 

2018, and allowed 30 days for public 

comment. No public comment was 

received in response to the notice. This 

notice announces our intent to submit 

this collection, which expires March 31, 

2022, to OMB for approval of an 

extension, and to solicit comments on 

specific aspects for the proposed 

information collection. Title: Purchased/ 

Referred Care Proof of Residency. OMB 

Control Number: 0917–0040. Need and 

Use of Information Collection: The IHS 

Purchased/Referred Care Program needs 

the information requested on the PRC 

Proof of Residency form to verify that 

individuals seeking medical services 

through a PRC program meet the 

residency requirements specific to PRC 

under 42 CFR 136.23. Agency Form 

Number: IHS 976. Members of Affected 

Public: Individuals/Households. Status 

of the Proposed Information Collection: 

Renewal request. Type of Respondents: 

Individuals. The table below provides: 

Types of data collection instruments, 

Estimated number of respondents, 

Number of responses per respondent, 

Annual number of responses, Average 

burden hour per response, and Total 

annual burden hours. 

Data collection instrument(s) 

Estimated 

number of 

respondents 

Responses 

per 

respondent 

Annual 

number of 

responses 

Average 

burden hour 

per response * 

Total annual 

burden hours 

Individual Patient Count ....................................................... 77,185 1 77,185 3/60 3,859.25 

Total .............................................................................. 77,185 1 77,185 3/60 3,859.25 

* For ease of understanding, the average burden per response is 3 minutes. 

There are no direct costs to 

respondents to report. 

Requests for Comments: Your written 

comments and/or suggestions are 

invited on one or more of the following 

points: 

(a) Whether the information collection 

activity is necessary to carry out an 

agency function; 

(b) whether the agency processes the 

information collected in a useful and 

timely fashion; 

(c) the accuracy of the public burden 

estimate (the estimated amount of time 

needed for individual respondents to 

provide the requested information); 

(d) whether the methodology and 

assumptions used to determine the 

estimates are logical; 

(e) ways to enhance the quality, 

utility, and clarity of the information 

being collected; and 

(f) ways to minimize the public 

burden through the use of automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology. 

Elizabeth A. Fowler, 

Acting Deputy Director, Indian Health 

Service. 

[FR Doc. 2022–01250 Filed 1–21–22; 8:45 am] 

BILLING CODE 4165–16–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Biobehavioral and 

Behavioral Processes Integrated Review 

Group; Adult Psychopathology and Disorders 

of Aging Study Section. 

Date: February 17–18, 2022. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Benjamin Greenberg 

Shapero, Ph.D., Scientific Review Officer, 

Center for Scientific, Review National 

Institutes of Health, 6701 Rockledge Drive, 

Room 3182, MSC 7848, Bethesda, MD 20892, 

(301) 402–4786, shaperobg@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Collaborative Applications: Clinical Studies 

of Mental Illness. 

Date: February 17, 2022. 

Time: 2:00 p.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Benjamin G. Shapero, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3182, 

Bethesda, MD 20892, (301) 402–4786, 

shaperobg@mail.nih.gov. 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group; 

Maximizing Investigators’ Research Award A 

Study Section. 

Date: February 22–23, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Elena Smirnova, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5187, 

MSC 7840, Bethesda, MD 20892, 301–357– 

9112, smirnove@csr.nih.gov. 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group; Molecular 

Genetics Study Section. 

Date: February 23–25, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Michael L. Bloom, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6187, 

MSC 7804, Bethesda, MD 20892, 301–451– 

0132, bloomm2@mail.nih.gov. 

Name of Committee: Cardiovascular and 

Respiratory Sciences Integrated Review 

Group; Integrative Myocardial Physiology/ 

Pathophysiology A Study Section. 

Date: February 23–24, 2022. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Abdelouahab Aitouche, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4222, 

MSC 7814, Bethesda, MD 20892, 301–435– 

2365, aitouchea@csr.nih.gov. 


jspears on DSK121TN23PROD with NOTICES1
3564 Federal Register / Vol. 87, No. 15 / Monday, January 24, 2022 / Notices 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Special 

Topics: Noninvasive Neuromodulation and 

Neuroimaging Technologies. 

Date: February 23, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Pablo M. Blazquez Gamez, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 435–1042, 

pablo.blazquezgamez@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Neurodevelopment, Synaptic 

Plasticity and Neurodegeneration. 

Date: February 23–25, 2022. 

Time: 12:00 p.m. to 9:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Tina Tze-Tsang Tang, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Suite 3030, 

Bethesda, MD 20817, (301) 435–4436, tangt@

mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Special 

Topics: Vision Imaging, Bioengineering and 

Low Vision Technology Development. 

Date: February 24–25, 2022. 

Time: 8:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Susan Gillmor, Ph.D., 

Scientific Review Officer, National Institutes 

of Health, Center for Scientific Review, 6701 

Rockledge Drive, Bethesda, MD 20892, 240– 

762–3076, susan.gillmor@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Biophysical, Physiological, 

Pharmacological and Bioengineering 

Neuroscience. 

Date: February 24–25, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Jennifer Kielczewski, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 435–1042, jennifer.kielczewski@

nih.gov. 

Name of Committee: Oncology 2— 

Translational Clinical Integrated Review 

Group; Cancer Prevention Study Section. 

Date: February 28-March 1, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Svetlana Kotliarova, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6214, 

Bethesda, MD 20892, 301–594–7945, 

kotliars@mail.nih.gov. 

Name of Committee: Biology of 

Development and Aging Integrated Review 

Group; Mechanisms of Cancer 

Therapeutics—2 Study Section. 

Date: February 28–March 1, 2022. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Careen K. Tang-Toth, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6214, 

MSC 7804, Bethesda, MD 20892, (301) 435– 

3504, tothct@csr.nih.gov. 

Name of Committee: Oncology 1-Basic 

Translational Integrated Review Group; 

Molecular Oncogenesis Study Section. 

Date: February 28–March 1, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Jian Cao, MD, Scientific 

Review Officer, Center for Scientific Review, 

6701 Rockledge Drive, Bethesda, MD 20892, 

301–827–5902, caojn@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Membrane Biochemistry and 

Biophysics. 

Date: February 28, 2022. 

Time: 10:00 a.m. to 8:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Sergei Ruvinov, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4158, 

MSC 7806, Bethesda, MD 20892, 301–435– 

1180, ruvinser@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Interdisciplinary Molecular Sciences and 

Training Member Conflict. 

Date: February 28, 2022. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: John Harold Laity, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 402–8254, john.laity@nih.gov. 

Information is also available on the 

Institute’s/Center’s home page: https://

public.csr.nih.gov/StudySections/DBIB/GGG, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 18, 2022. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–01230 Filed 1–21–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Advancing 

Translational Sciences; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Advancing Translational Sciences Special 

Emphasis Panel; CTSA Collaborative 

Innovation Awards Review Meeting. 

Date: February 23, 2022. 

Time: 11:00 a.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, 6701 Democracy Boulevard, Room 

1037, Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: M. Lourdes Ponce, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review, National Center for Advancing 

Translational Sciences, National Institutes of 

Health, 6701 Democracy Boulevard, Room 

1037, Bethesda, MD 20892, 301–435–0810, 

lourdes.ponce@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.350, B—Cooperative 

Agreements; 93.859, Biomedical Research 

and Research Training, National Institutes of 

Health, HHS) 


jspears on DSK121TN23PROD with NOTICES1